Purified complement C3b triggers phagocytosis and activation of human neutrophils via complement receptor 1.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
06 01 2023
Historique:
received: 09 05 2022
accepted: 29 12 2022
entrez: 7 1 2023
pubmed: 8 1 2023
medline: 11 1 2023
Statut: epublish

Résumé

The complement system provides vital immune protection against infectious agents by labeling them with complement fragments that enhance phagocytosis by immune cells. Many details of complement-mediated phagocytosis remain elusive, partly because it is difficult to study the role of individual complement proteins on target surfaces. Here, we employ serum-free methods to couple purified complement C3b onto E. coli bacteria and beads and then expose human neutrophils to these C3b-coated targets. We examine the neutrophil response using a combination of flow cytometry, confocal microscopy, luminometry, single-live-cell/single-target manipulation, and dynamic analysis of neutrophil spreading on opsonin-coated surfaces. We show that purified C3b can potently trigger phagocytosis and killing of bacterial cells via Complement receptor 1. Comparison of neutrophil phagocytosis of C3b- versus antibody-coated beads with single-bead/single-target analysis exposes a similar cell morphology during engulfment. However, bulk phagocytosis assays of C3b-beads combined with DNA-based quenching reveal that these are poorly internalized compared to their IgG1 counterparts. Similarly, neutrophils spread slower on C3b-coated compared to IgG-coated surfaces. These observations support the requirement of multiple stimulations for efficient C3b-mediated uptake. Together, our results establish the existence of a direct pathway of phagocytic uptake of C3b-coated targets and present methodologies to study this process.

Identifiants

pubmed: 36609665
doi: 10.1038/s41598-022-27279-4
pii: 10.1038/s41598-022-27279-4
pmc: PMC9822988
doi:

Substances chimiques

Complement C3b 80295-43-8
Receptors, Complement 3b 0
Complement System Proteins 9007-36-7
Immunoglobulin G 0
Receptors, Complement 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

274

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM098060
Pays : United States

Informations de copyright

© 2023. The Author(s).

Références

Proc Natl Acad Sci U S A. 2021 Feb 16;118(7):
pubmed: 33563762
Adv Immunol. 1989;46:183-219
pubmed: 2551147
J Exp Med. 1982 Oct 1;156(4):1149-64
pubmed: 7153708
Immunol Rev. 2001 Apr;180:112-22
pubmed: 11414353
Nat Cell Biol. 2019 Nov;21(11):1357-1369
pubmed: 31659275
PLoS One. 2015 Jun 12;10(6):e0129522
pubmed: 26070210
J Exp Med. 1977 Feb 1;145(2):357-71
pubmed: 833545
Cell Regul. 1991 Jan;2(1):41-55
pubmed: 1826092
Am J Blood Res. 2017 Jul 25;7(4):41-48
pubmed: 28804681
Mol Biol Cell. 2008 Nov;19(11):4628-39
pubmed: 18768756
Biochim Biophys Acta. 1986 Nov 4;853(1):65-89
pubmed: 3021215
J Exp Med. 2017 May 1;214(5):1509-1528
pubmed: 28389502
Clin Immunol Immunopathol. 1982 May;23(2):335-57
pubmed: 7049467
Trends Biotechnol. 2013 Apr;31(4):258-67
pubmed: 23490213
J Immunol. 1983 Oct;131(4):1930-5
pubmed: 6225800
J Biol Chem. 2021 Jan-Jun;296:100256
pubmed: 33839682
Immunol Rev. 2016 Nov;274(1):33-58
pubmed: 27782325
J Exp Med. 1996 Aug 1;184(2):627-37
pubmed: 8760816
Nat Commun. 2022 Apr 12;13(1):1955
pubmed: 35413960
Blood Cells Mol Dis. 2009 May-Jun;42(3):177-84
pubmed: 19246218
Microbes Infect. 2000 Mar;2(3):289-94
pubmed: 10758405
Microbiol Spectr. 2016 Nov;4(6):
pubmed: 27809953
J Cell Biol. 1994 Jun;125(6):1407-16
pubmed: 7515890
Cell. 2016 Jan 14;164(1-2):128-140
pubmed: 26771488
J Immunol. 1993 Jul 1;151(1):330-8
pubmed: 8326130
Plasmid. 2016 Sep - Nov;87-88:65-71
pubmed: 27693407
J Immunol. 1979 Oct;123(4):1839-46
pubmed: 573303
J Biol Chem. 2003 Nov 14;278(46):45720-9
pubmed: 12941957
Biomed Res Int. 2017;2017:9042851
pubmed: 28691037
J Exp Med. 1985 Jun 1;161(6):1414-31
pubmed: 2409200
Immunology. 1987 May;61(1):15-20
pubmed: 2953672
PLoS One. 2013;8(1):e54735
pubmed: 23349959
Mol Immunol. 2004 Nov;41(11):1089-98
pubmed: 15476920
Clin Exp Immunol. 1998 Apr;112(1):27-33
pubmed: 9566786
J Immunol. 1994 Jul 15;153(2):804-10
pubmed: 8021514
Nat Rev Immunol. 2019 Aug;19(8):503-516
pubmed: 31048789
J Immunol. 1999 Feb 15;162(4):2266-74
pubmed: 9973503
Biochemistry. 2015 Feb 17;54(6):1408-20
pubmed: 25613106
J Cell Biol. 1993 Feb;120(4):1031-43
pubmed: 7679388
BMC Biol. 2015 Nov 09;13:93
pubmed: 26552476
Scand J Immunol. 1977;6(8):797-807
pubmed: 561436
Cell Mol Bioeng. 2010 Jun 1;3(2):106-116
pubmed: 21532911
J Leukoc Biol. 1996 Jun;59(6):883-90
pubmed: 8691074
Cytometry. 1991;12(7):677-86
pubmed: 1838328
Nat Struct Mol Biol. 2017 Aug;24(8):643-651
pubmed: 28671664
Clin Exp Immunol. 1992 Jul;89(1):8-17
pubmed: 1385769
Int J Med Microbiol. 2015 Jan;305(1):55-64
pubmed: 25466204
PLoS Comput Biol. 2011 Jan 27;7(1):e1001068
pubmed: 21298079
J Exp Med. 1983 Jun 1;157(6):1844-54
pubmed: 6854210
Proc Natl Acad Sci U S A. 2013 Oct 8;110(41):16426-31
pubmed: 24065820
Complement. 1987;4(2):75-86
pubmed: 3040333
Proc Natl Acad Sci U S A. 2017 Mar 28;114(13):3403-3408
pubmed: 28292891
Clin Immunol Immunopathol. 1997 Jan;82(1):49-59
pubmed: 9000042
Complement. 1984;1(4):213-27
pubmed: 6242391
Blood. 2015 Apr 9;125(15):2359-69
pubmed: 25608561
Proc Natl Acad Sci U S A. 2021 Jun 29;118(26):
pubmed: 34155115
Cytokine. 1990 Nov;2(6):447-55
pubmed: 1716488
Langmuir. 2005 Mar 1;21(5):1962-71
pubmed: 15723496
J Leukoc Biol. 1985 Aug;38(2):267-78
pubmed: 2993460
J Clin Invest. 1989 Jul;84(1):107-12
pubmed: 2544621
J Cell Sci. 2011 Apr 1;124(Pt 7):1106-14
pubmed: 21385838
ACS Chem Biol. 2006 Nov 21;1(10):644-8
pubmed: 17175580
Biophys J. 2015 Aug 4;109(3):469-76
pubmed: 26244729
Immunity. 2006 Mar;24(3):305-16
pubmed: 16546099
J Immunol. 2002 Dec 1;169(11):6417-26
pubmed: 12444150
J Immunol. 1989 Apr 1;142(7):2352-8
pubmed: 2538507
J Cell Sci. 2006 May 1;119(Pt 9):1903-13
pubmed: 16636075
mBio. 2013 Apr 16;4(2):e00065
pubmed: 23592259
J Immunol. 1984 Jun;132(6):3028-33
pubmed: 6233366
J Vis Exp. 2013 Jul 17;(77):e50788
pubmed: 23893048
Microbiol Spectr. 2016 Jun;4(3):
pubmed: 27337463
Scand J Immunol. 1990 Dec;32(6):669-77
pubmed: 2148644
Sci Signal. 2018 Mar 13;11(521):
pubmed: 29535263
J Cell Sci. 2005 Nov 15;118(Pt 22):5205-20
pubmed: 16249234
Immunology. 1987 Sep;62(1):45-51
pubmed: 3653927
Blood. 2001 Apr 15;97(8):2478-86
pubmed: 11290613

Auteurs

Elena Boero (E)

Department of Medical Microbiology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
GSK, 53100, Siena, Italy.

Ronald D Gorham (RD)

Department of Medical Microbiology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
Sanofi, Waltham, MA, 02451, USA.

Emmet A Francis (EA)

Department of Biomedical Engineering, University of California Davis, Davis, CA, 95616, USA.

Jonathan Brand (J)

Department of Biomedical Engineering, University of California Davis, Davis, CA, 95616, USA.

Lay Heng Teng (LH)

Department of Biomedical Engineering, University of California Davis, Davis, CA, 95616, USA.

Dennis J Doorduijn (DJ)

Department of Medical Microbiology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.

Maartje Ruyken (M)

Department of Medical Microbiology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.

Remy M Muts (RM)

Department of Medical Microbiology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.

Christian Lehmann (C)

Laboratory of Dendritic Cell Biology, Department of Dermatology, University Hospital of Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, 91052, Erlangen, Germany.

Admar Verschoor (A)

Department of Otorhinolaryngology, Technische Universität München and Klinikum Rechts der Isar, 81675, Munich, Germany.

Kok P M van Kessel (KPM)

Department of Medical Microbiology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.

Volkmar Heinrich (V)

Department of Biomedical Engineering, University of California Davis, Davis, CA, 95616, USA.

Suzan H M Rooijakkers (SHM)

Department of Medical Microbiology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. s.h.m.rooijakkers@umcutrecht.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH